API (active pharmaceutical ingredient):

Transcrição

API (active pharmaceutical ingredient):
API (active pharmaceutical ingredient):
#
C
6- APA (6-amino-penicillanic acid)
7-ADCA (7-amino-deacetoxycephalosporanic acid)
CALCIUM DOBESILATE
CALCIUM PHOSPHORYLCOLINE
CALCIUM PHOSPHORYLCOLINE CHLORIDE
CARBAMAZEPINE
CARBOCISTEINE
CARISOPRODOL
CARTEOLOL
CARTEOLOL HYDROCHLORIDE
CARVEDILOL
CASPOFUNGINA ACETATO
CEFACLOR
CEFADROXIL MONOHYDRATE
CEPHALEXIN MONOHYDRATE
CETIRIZINE 2HCL
CETRIMIDE
CHLORDIAZEPOXIDE
CHLORDIAZEPOXIDE HYDROCHLORIDE
CHLORMEZANONE
CHLORPHENIRAMINE MALEATE
CHLORPROMAZINE HCL
CHLORTHALIDONE
CHYMOTRYSIN
CIMETIDINE
CITALOPRAM
CITICOLINE
CLARITHROMYCIN
CLAVULANATO POTASSIO
(avicel and siloire)
CLAVULANATO POTASSIO STERILE
CLIDINIUM BROMIDE
CLOBAZAM
CLODRONATE DISODIUM
CLOMIFENE CITRATE
CLOMIPRAMINE HCL
CLONAZEPAM
CLONIDINE BASE
CLONIDINE HCL
CLOPAMIDE
CLOTRIMAZOLE
CLOXACILLIN SODIUM (compacted and powder)
CYPROHEPTADINE HCL
A
ACEBUTOLOL
ACETAZOLAMIDE
ACYCLOVIR
ADENOSINE
ALLOPURINOL
AMBROXOL
AMILORIDE
AMILORIDE HCL
AMITRIPTYLINE HCL
AMOXICILLIN ANHYDROUS
(compacted and powder)
AMOXICILLIN TRIHYDRATE
(compacted and powder)
AMPICILLIN TRIHYDRATE
(compacted and powder)
ANAGRELIDE
ANTAZOLINE SULPHATE
ANTAZOLYNE HCL
ARTICAINE HCL
ARTEETHER
ARTESUNATE
ASPARTAME
ATENOLOL
ATORVASTATIN
AZITHROMYCIN
B
BACLOFEN
BENIDIPINE
BENIDIPINE HCL
BENZHEXOL HCL (TRIHEXYPHENYDIL HCL)
BENZYDAMINE HCL
BETAHISTINE 2HCL
BETAINE HCL
BETAXOLOL HYDROCHLORIDE
BICALUTAMIDE
BIFEMELANE
BISACODYL (PHENYLAX)
BROMAZEPAM
BROMHEXINE HCL
BROMOPRIDE
BUFEXAMAC
BUFLOMEDIL HCL
BUPIVACAINE HCL
D
DELOEAZEPAM
DEQUALINIUM CHLORIDE
DEXTROMETORPHAN HYDROBROMIDE
DIAVERIDINE HCL
DIAZEPAM
DICLOFENAC SODIUM
DICLOXACILLIN (compacted and powder)
DIHYDROARTEMISININ
DIHYDROXYDIBUTYLETHER
DIISOPROPYLAMINE DICHLOROACETATE
DILTIAZEM HCL
DILTIAZEN HYDROCHLORIDE
DIMENHYDRINATE
DIPHENHYDRAMINE CITRATE
DIPHENHYDRAMINE HCL
DIPYRIDAMOLE
DISODIUM CLODRONATE
DISODIUM CROMOGLICATE
DISOPYRAMIDE BASE AND PHOSPHATE
D-L CLOPERASTINE FENDIZOATE
D-L CLOPERASTINE HCL
D-L DROPROPIZINE
DOBUTAMINE HCL
DOCUSATE SODIUM
DOPAMINE HCL
E
ENTACAPONE
ERYTHROMYCIN BASE
ERYTHROMYCIN ESTOLATE
ERYTHROMYCIN ETHYL SUCCINATE
ERYTHROMYCIN OXIME (intermediate)
ERYTHROMYCIN SALTS
ERYTHROMYCIN STEARATE
ESTAZOLAM
ETHAMBUTOL 2 HCL
ETHANOL-2-AMINO PHOSPHORIC ACID
ETHIONAMIDE
ETODOLAC
F
FENOTEROL
FENOTEROL HYDROBROMIDE
FENSPIRIDE
FEXOFENADINE
FLECAINIDE ACETATE
FLUCLOZACILLIN SODIUM
(compacted and powder)
FLUCYTOSINE
FLUFENAMIC ACID
FLUNARIZINE DIHYDRICHLORIDE
FLUNITRAZEPAM
FLUOROMETHOLONE
FLUOXETINE HCL
FLUPHENAZINE DECANOATE
FLURAZEPAM
FLURAZEPAM DIHYDROCHLORIDE
FLURAZEPAM HYDROCHLORIDE
FLUTAMIDE
FORMOTEROL FUMARATE
NOTE: The aforementioned products shall not be used in any country where such products are covered by patents other than for research and development purposes, in compliance with applicable
laws and regulations, including Article 10.6 of Directive 2001/83/EC and corresponding national provisions.
NOTA: Os produtos acima referidos só poderão ser utilizados para fins de pesquisa e desenvolvimento em todos os países em que estejam sob protecção de patente, de acordo com as leis e
regulamentos em vigor, incluindo o artigo 10.6 da Directiva 2001/83/CE e respectiva legislação nacional
1/3
API (active pharmaceutical ingredient):
FOSPHENYTOIN
FUROSEMIDE
G
GEMFIBROZIL
GLIBENCLAMIDE
GLICAZIDE
GLIPIZIDE
GLYCOFUROL (TETRAGLYCOL)
GLYCOPYRROLATE
H
HALOPERIDOL
HYDROCHLOROTHIAZIDE
HYDROXYZINE 2HCL / PAMOATE
HYDROXYZINE HCL / PAMOATE
I
IBUPROFEN LYSINATE
IMIPRAMINE HCL
INDAPAMIDE
INDOMETHACIN
INDORAMIN HYDROCHLORIDE
IPRATROPIUM BROMIDE
IRBESARTAN
ISOCONAZOLE NITRATE
ISONIAZID
ISOXSUPRINE HCL
ITRACONAZOLE
K
KETAZOLAM
KETOPROFEN
KETOPROFEN LYSINATE
KETOROLAC
KETOTIFEN FUMARATE
L
LABETALOL HCL
LACTULOSE 50%
LANZOPRAZOLE
LEFLUNOMIDE
LIDOCAINE BASE
LIDOCAINE HCL
LOPERAMIDE
LORAZEPAM
LOSARTAN POTASSIUM
LUMEFANTRINE
LYSINE ACETYLSALICYLATE
M
MANIDIPINE
MANIDIPINE DIHYDROCHLORIDE
MEBENDAZOLE POLYMORPH “C”
MEBENDAZOLE USP WHITE
MEBEVERINE HCL
MEFENAMIC ACID
MELOXICAM
MEMANTINE
MEMANTINE HCL / BASE
MEPENZOLATE BROMIDE
MEPIFILLINE
MEPIVACAINE HCL
MESALAZINE
METFORMIN
METFORMIN HCL
METHYLTHIOURACIL
METOCLOPRAMIDE
METOCLOPRAMIDE BASE / HCL / 2HCL
METOPROLOL SUCCINATE
METOPROLOL TARTRATE
MIANSERINA HCL
MICAFUNGIN
MICONAZOLE BASE-NITRATE
MINOXIDIL
MORANTEL CITRATE AND TARTRATE
MOXIFLOXACIN
N
NALIDIXIC ACID
NATEGLINIDE
NEOMYCIN SULPHATE
NICARDIPINE HYDROCHLORIDE
NICLOSAMIDE
NIFEDIPINE HCL
NIMESULIDE
NIMODIPINE
NISOLDIPINE
NITRAZEPAM
NITRENDIPINE
NITROFURANTOIN MONOHYDRATE
NITROFURANTOIN (regular or macro crystals)
NITROXOLINE
NONOXYNOL 9
NYLIDRINE HCL (BUPHENINE HCL)
NYSTATIN
NYSTATIN CRUDE (MYCELIUM)
NYSTATIN POWDER
O
ORCIPRENALINE SULFATE
ORPHENADRINE CITRATE
ORPHENADRINE HCL
OXACILLIN SODIUM (compacted and powder)
OXANTEL PAMOATE
OXAPROZIN
OXAZEPAM
OXCARBAZEPINE
OXOLAMINE CITRATE AND PHOSPHATE
OXYMETHOLONE
P
PAMOIC ACID/SODIUM PAMOATE
PANCREATIN
PANTETHINE 80%
PAPAVERINE HCL
PENICILLIN G POTASSIUM, NON STERILE
PENICILLIN G PROCAINE, NON STERILE
PENTAZOCINE
PENTAZOCINE HYDROCHLORIDE
PHENFORMIN HYDROCHLORIDE
PHENYTOIN
PHENYTOIN SODIUM
PHOSPHOCREATINE SODIUM
PHOSPHORYLCOLAMINE
PINDOLOL
PIPEMIDIC ACID
PIPENZOLATE METHYLBROMIDE
PIRACETAM
PIROXICAM
PIZOTIFEN MALATE
PRAZOSIN
PRENOXIDIAZINE
PRENOXIDIAZINE HIBENZOATE
PRIDINOL MESYLATE
PROCETOFEN
PROCLORPERAZINE MALEATE
PROMETHAZINE HCL
PROPRANOLOL HCL
PYRANTEL PAMOATE
PYRANTEL PAMOATE /TARTRATE
PYRANTEL TARTRATE
PYRAZINAMIDE
PYRIDOXAL-5-PHOSPHATE
PYRISUCCIDEANOL DIMALEATE
PYRITHIOXINE HCL OR PYRITINOL HCL
Q
QUETIAPINE FUMARATE
R
RANITIDINE FORM 1+ FORM 2
RANOLAZINE
REPROTEROL HYDROCHLORIDE
NOTE: The aforementioned products shall not be used in any country where such products are covered by patents other than for research and development purposes, in compliance with applicable
laws and regulations, including Article 10.6 of Directive 2001/83/EC and corresponding national provisions.
NOTA: Os produtos acima referidos só poderão ser utilizados para fins de pesquisa e desenvolvimento em todos os países em que estejam sob protecção de patente, de acordo com as leis e
regulamentos em vigor, incluindo o artigo 10.6 da Directiva 2001/83/CE e respectiva legislação nacional
2/3
API (active pharmaceutical ingredient):
RITODRINE HYDROCHLORIDE
ROLITETRACYCLINE
ROSUVASTATIN
ROSUVASTATIN CALCIUM
S
Z
ZALTROPROFENE
ZEAXANTINE
ZIDOVIDINE
ZOPICLONE
SACCHARINS
SALBUTAMOL BASE AND SULPHATE
SERTRALINE HCL
SILVER SULPHADIAZINE
SOTALOL HCL
SPIRONOLACTONE
STANAZOLOL
SUCRALFATE
SULFINPYRAZONE
SULPIRIDE
T
TELMISARTAN
TEMAZEPAN
TERAZOSIN HCL 2H2O
TERBUTALINE SULFATE
TETRABENAZINE
TETRAHYDROZOLINE HCL
TETRAZEPAM
THEOPHYLLINE ETHYLENDIAMINE
THIABENDAZOLE
THIOCTIC ACID
THIORIDAZINE BASE AND HCL
TIAPRIDE
TICLOPIDINE
TICLOPIDINE HCL
TIRATRICOL (TRIAC)
TOLAZAMIDE
TOLMETIN SODIUM
TOLNAFTATE
TORASEMIDA
TRAMADOL
TRIBENOSIDE
TRICHLORMETHIAZIDE
TRICLABENDAZOLE
TRIFLUOPERAZINE HCL
TRIMEBUTINE MALEATE
TRIPROLIDINE
TROXERUTIN
TYLOSIN TARTRATE
V
VERALIPRIDA
VERAPAMIL HCL
VIDARABINA
VINCAMINA BASE
NOTE: The aforementioned products shall not be used in any country where such products are covered by patents other than for research and development purposes, in compliance with applicable
laws and regulations, including Article 10.6 of Directive 2001/83/EC and corresponding national provisions.
NOTA: Os produtos acima referidos só poderão ser utilizados para fins de pesquisa e desenvolvimento em todos os países em que estejam sob protecção de patente, de acordo com as leis e
regulamentos em vigor, incluindo o artigo 10.6 da Directiva 2001/83/CE e respectiva legislação nacional
3/3